Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Intangibles (2021 - 2022)

Whitehawk Therapeutics (WHWK) has disclosed Intangibles for 2 consecutive years, with $3.7 million as the latest value for Q1 2022.

  • Quarterly Intangibles changed N/A to $3.7 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $3.7 million through Mar 2022, changed N/A year-over-year, with the annual reading at $3.8 million for FY2021, N/A changed from the prior year.
  • Intangibles for Q1 2022 was $3.7 million at Whitehawk Therapeutics, down from $3.8 million in the prior quarter.
  • The five-year high for Intangibles was $3.9 million in Q3 2021, with the low at $3.7 million in Q1 2022.